CAS: 56904-09-7

Benzyl[2-(methylamino)ethyl]amine is a dopaminergic drug that has been shown to have cytotoxic effects. It has been shown to inhibit the proliferation of tumor xenografts in mice and is also known to have antitumor properties. Benzyl[2-(methylamino)ethyl]amine has also been shown to be an inhibitor of topoisomerase II, which can lead to DNA damage. The cytotoxicity of this drug may be due to its ability to inhibit bromopride-sensitive dopamine receptors in human tumor xenografts and domperidone-sensitive dopamine receptors in human tumor xenografts. This drug also inhibits the hydrolysis of metoclopramide by esterases, leading to increased levels of metoclopramide in the blood.

Benzyl[2-(methylamino)ethyl]amine